IDStewardship

OCTOBER 18, 2023

In this article the students from the University of Florida discuss why they started the ChatRx podcast and what their goals are for their new endeavor. Written By: Eisha Ludtke, Pharm.D. Candidate 2024 & Lucas Zhou, Pharm.D. Candidate 2024 Article Posted October 2024 Hello Readers of IDstewardship! My name is Eisha Ludtke, and I am a 4th year pharmacy student at the University of Florida (UF).

182

182

Pharmacy Times

OCTOBER 18, 2023

Artificial intelligence and machine learning can significantly benefit managed care pharmacy, specifically in contract reading and interpretation.

158

158

STAT

OCTOBER 18, 2023

Meta founder Mark Zuckerberg and his wife, pediatrician and philanthropist Priscilla Chan, announced on Wednesday plans to invest $250 million over 10 years to establish a new “biohub” in New York City focused on building a new class of cellular machines that can surveil the body and snuff out disease. The new initiative, publicly revealed at the 2023 STAT Summit and previewed exclusively to STAT, is the latest program from the Chan Zuckerberg Initiative, or CZI, a company the coup

145

145

Pharmacy Times

OCTOBER 18, 2023

As pharmacists provide more health care services, opportunities arise for more sophisticated patient engagement and billing solutions that drive patient satisfaction and increased loyalty.

139

139

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

OCTOBER 18, 2023

Stephen Hemsley, the former CEO of UnitedHealth Group and its current board chair, also owns an investment firm that manages his own portfolio of UnitedHealth stock and oversees other wealthy individuals’ accounts that have held shares of companies that have direct business with or indirect ties to United. It’s an unusual arrangement for someone in such a prominent role at one of the largest health care corporations in the world, according to several experts in securities and corpo

Insurance 139

Insurance 139

Fierce Healthcare

OCTOBER 18, 2023

Seniors are forced to navigate a convoluted Medicare Advantage (MA) landscape for healthcare coverage, often only to be denied care, experts told legislators during a Senate Finance Committee heari | Senators and experts agreed Wednesday that marketing practices from Medicare Advantage plans are often overwhelming for seniors.

138

138

STAT

OCTOBER 18, 2023

Laurie Glimcher trained at Massachusetts General Hospital. Her father was the chair of orthopedic surgery there, and her son is currently a thoracic surgeon at the hospital. But Glimcher, the CEO of the neighboring Dana-Farber Cancer Institute , has no qualms about the contentious decision to sever a 30-year partnership with Massachusetts General’s parent organization.

Hospitals 132

Hospitals 132

Pharmacy Times

OCTOBER 18, 2023

Twice-daily tenapanor tablets are recommended for patients with chronic kidney disease who are on dialysis, unresponsive or intolerant of any dose of a phosphate binder therapy.

FDA 122

FDA 122

Fierce Pharma

OCTOBER 18, 2023

Editor's Note: Please check back on Oct. 22 when the full data of EV-302 are presented at ESMO 2023. | The results are in for a phase 3 bladder cancer trial assessing the combination of Seagen and Astellas' Padcev, plus Merck's Keytruda, versus standard of care chemotherapy. The figures indicate that the combo can be transformative in the indication.

Chemotherapy 129

Chemotherapy 129

Pharmacy Times

OCTOBER 18, 2023

Medically integrated dispensing specialty pharmacies can connect patient medical and pharmacy records to improve medication adherence and help patients to safely stay on them for longer.

Medical Records 123

Medical Records Specialty Pharmacies 123

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

OCTOBER 18, 2023

Senate Finance Committee members from both parties took aim Wednesday at insurance brokers that sell plans for large Medicare Advantage insurers. Older adults at times have more than 100 plan options, and brokers help them choose the right one. But brokers can be incentivized by large insurance companies to aggressively sell plans that are a poor fit for the Medicare beneficiaries they’re supposed to help.

Insurance 128

Insurance 128

Pharmacy Times

OCTOBER 18, 2023

Areas of focus for specialty medications include biosimilars, cancer treatments, and drugs across disease states such as inflammatory conditions, HIV, and multiple sclerosis.

123

123

STAT

OCTOBER 18, 2023

Back in the 1990s, scientist Lotte Bjerre Knudsen was tasked with revitalizing a floundering program at Novo Nordisk that had been trying to harness the newly-discovered GLP-1 hormone into viable diabetes drug candidates. At the time, many of Knudsen’s bosses had already lost hope for the program. Novo’s focus, after all, was on insulin, and the naturally occurring GLP-1 hormone had too short a half-life to use as a drug.

127

127

Pharmacy Times

OCTOBER 18, 2023

PLCOm2012 uses additional parameters to predict the risk of lung cancer and was found more effective when identifying both Indigenous and non-Indigenous individuals with lung cancer.

122

122

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

STAT

OCTOBER 18, 2023

DALLAS — Treatments like Ozempic, Wegovy, and Mounjaro have been hailed for showing 15% to over 20% weight loss in trials, but those are just averages. In reality, there are big variations in how much weight people lose on the therapies, and it’s unclear what explains those differences. One way researchers are trying to figure this out is by focusing on genes.

127

127

Pharmacy Times

OCTOBER 18, 2023

Following the results of a meta-analysis that reviewed biosimilar trial design and endpoints, investigators urge for greater biosimilar uptake initiatives.

131

131

Fierce Pharma

OCTOBER 18, 2023

Pfizer will cough up $2 million to settle allegations from the U.S. Department of Labor that it underpaid certain women who were employed at the company’s New York City headquarters. | The accusations centered on the company's compensation of 86 female employees in 2015 and 2016. Under the settlement with the Department of Labor, the company must also set aside $500,000 for potential future salary adjustments.

126

126

STAT

OCTOBER 18, 2023

During a nearly two-decade stint as Alnylam’s founding CEO, John Maraganore took a promising but unproven approach for treating genetic disease and built a new class of medicines and what is now a nearly $21 billion company. His next goal? Helping the next generation of budding biotech entrepreneurs. Since stepping down as Alnylam CEO in 2021, Maraganore has spent much of his time passing down his knowledge to up-and-coming biotech CEOs.

125

125

Fierce Healthcare

OCTOBER 18, 2023

Henry Ford Health is coming together with several of Ascension Michigan’s hospitals and other facilities to form a joint venture with over $10.5 billion in annual operating revenue, the organizatio | Should the deal close, the resulting organization would span 13 acute care hospitals and over 550 sites of care. The nonprofits stressed that the arrangement is not a merger and that "no cash transaction" would take place.

Hospitals 124

Hospitals 124

Pharmacy Times

OCTOBER 18, 2023

Jeff J, Mclntyre, MA, Vice President of Liver Health Programs, Global Liver Institute, discussed the clinical and economic burden of NASH

132

132

Fierce Pharma

OCTOBER 18, 2023

UCB is on an approval roll. | UCB is on an approval roll. Within hours of each other, the Brussels-based company has scored FDA green lights for plaque psoriasis treatment Bimzelx and for generalized myasthenia gravis (gMG) drug Zilbrysq. Not only that, the Zilbrysq endorsement is UCB’s second in the indication this year, coming on top of the FDA signing off on UCB’s Rystiggo in June.

FDA 121

FDA 121

Pharmacy Times

OCTOBER 18, 2023

Grace Yun, PharmD, and pharmacy manager at St. Francis Hospital, discussed the value of the pharmacist and how she sees the future of pharmacy evolving.

Hospitals 123

Hospitals 123

STAT

OCTOBER 18, 2023

Since the early days of the pandemic, long Covid has haunted us: Even a mild acute infection might leave you with life-altering consequences. And for many, that has, sadly, turned out to be the case. While research suggests long Covid rates are falling, it still affects millions. In June 2023, 6% of Americans reported experiencing long Covid. But what if long Covid isn’t the right way to think about what they are going through?

119

119

Pharmacy Times

OCTOBER 18, 2023

The Act is part of a federal attempt to streamline the research process for medical marijuana and provide more attainable security requirements

126

126

STAT

OCTOBER 18, 2023

At the age of 26, Lauren Ghazal was diagnosed with Hodgkin’s lymphoma just months into her Ph.D. program in nursing theory at New York University. She experienced firsthand how the financial burden of undergoing cancer treatment, along with the emotional and physical toll of the disease itself, can lead to overwhelming distress in patients. Now, as an assistant professor at the University of Rochester in the School of Nursing, she researches health and quality of life outcomes among young

119

119

Fierce Healthcare

OCTOBER 18, 2023

CalOptima Health, the Medi-Cal managed care plan for Orange County, is awarding $52.3 million in grants to accelerate the creation of affordable and permanent housing. | The grants will go to 15 grantees to acquire, construct and upgrade a total of 706 housing units to support people experiencing homelessness.

119

119

Pharmacy Times

OCTOBER 18, 2023

The approval marks the first and only once-daily target therapy for generalized myasthenia gravis for self-administration in this patient population.

FDA 123

FDA 123

Fierce Healthcare

OCTOBER 18, 2023

Washington hospitals are looking to take their state’s Department of Health to court over a September notice requiring certain providers to offer charity care to poor patients regardless of where i | The Washington State Hospital Association wrote in a filing that the update is inconsistent with decades of charity care policy implementations and would make their facilities a hotspot for costly medical tourism.

Hospitals 117

Hospitals 117

European Pharmaceutical Review

OCTOBER 18, 2023

The US Food and Drug Administration (FDA) has approved XPHOZAH ® (tenapanor), the first and only phosphate absorption inhibitor. Ardelyx’s first-in-class oral treatment is indicated to reduce serum phosphorus in adults with chronic kidney disease ( CKD ) on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant to phosphate binder therapy.

FDA 114

FDA Adverse Reactions Labelling 114

Fierce Pharma

OCTOBER 18, 2023

UCB has been “eagerly awaiting” an FDA approval for its psoriasis therapy Bimzelx (bimekizumab) after manufacturing problems resulted in a rejection last May. Now, the wait is over. | The FDA rejected the drug last May after conducting an inspection at UCB's Belgian manufacturing plant. That followed a prior delay due to COVID-related inspection hold ups.

FDA 114

FDA 114

Pharmaceutical Technology

OCTOBER 18, 2023

The FDA approved Hyloris’s non-opioid painkiller as the agency increases efforts to mitigate an opioid crisis.

FDA 145

FDA 145

Fierce Healthcare

OCTOBER 18, 2023

Elevance Health reported $1.3 billion in profit for the third quarter, beating the Street but falling short of the prior-year quarter's haul. | Elevance Health reported $1.3 billion in profit for the third quarter, beating the Street but falling short of the prior-year quarter's haul.

112

112

Fierce Pharma

OCTOBER 18, 2023

After years spent challenging a tax break fee tethered to its massive Shire buyout, Takeda has settled with Irish authorities. | Takeda will pay €130 million (about $137 million) to resolve a tax assessment from the Irish Revenue Commissioners, the company said Wednesday. Back in 2018, Irish authorities hit Shire with a €398 million charge tied to that company’s rejection of AbbVie’s takeover bid in 2014.

110

110

Fierce Healthcare

OCTOBER 18, 2023

Healthcare payment software maker Waystar filed for an initial public offering, signaling a potential end to the dry spell in the health tech IPO market. | Healthcare payment software maker Waystar filed for an initial public offering, signaling a potential end to the dry spell in the health tech IPO market.

110

110